2007
DOI: 10.1016/j.abb.2007.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Conformational dynamics in the F/G segment of CYP51 from Mycobacterium tuberculosis monitored by FRET

Abstract: A cysteine was introduced into the FG-loop (P187C) of CYP51 from Mycobacterium tuberculosis (MT) for selective labeling with BODIPY and fluorescence energy transfer (FRET) analysis. Forster radius for the BODIPY-heme pair was calculated assuming that the distance between the heme and Cys187 in solution corresponds to that in the crystal structure of ligand free MTCYP51. Interaction of MTCYP51 with azole inhibitors ketoconazole and fluconazole or the substrate analog estriol did not influence the fluorescence, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 47 publications
1
8
0
Order By: Relevance
“…The lack of conformational changes in response to inhibitor binding in the CYP51 crystal structures is in a good agreement with our previous FRET-based data (in the solution) that detected no conformational changes in the CYP51 from Mycobacterium tuberculosis upon binding of ketoconazole, fluconazole, or the substrate analog estriol (16). The same experiments, however, demonstrated up to 10 Å movement in the enzyme FG arm (FЉ helix) in response to the binding of the substrate lanosterol, thus strongly suggesting that large-scale conformational dynamics must still be involved in CYP51 catalysis, and the evidence for this is provided for the first time in this study.…”
supporting
confidence: 92%
“…The lack of conformational changes in response to inhibitor binding in the CYP51 crystal structures is in a good agreement with our previous FRET-based data (in the solution) that detected no conformational changes in the CYP51 from Mycobacterium tuberculosis upon binding of ketoconazole, fluconazole, or the substrate analog estriol (16). The same experiments, however, demonstrated up to 10 Å movement in the enzyme FG arm (FЉ helix) in response to the binding of the substrate lanosterol, thus strongly suggesting that large-scale conformational dynamics must still be involved in CYP51 catalysis, and the evidence for this is provided for the first time in this study.…”
supporting
confidence: 92%
“…This was proposed for many soluble cytochromes P450 based on available X-ray structures of CYP101 [16-17], CYP158A2 [47], CYP107L1 [44], CYP113 [45], and CYP51 [48]. However, in cytochromes P450 that are membrane bound this loop connecting F and G helices is extended and usually includes additional F’ and / or G’ helices, which interact with and are inserted into the lipid bilayer.…”
Section: Discussionmentioning
confidence: 99%
“…SRS1 represents the major CYP51 substrate binding area. It carries the family signature 1 (13), the conserved or phylumspecific residues that are essential for enzyme function (37,51,52). In the T. brucei CYP51 complex with the substrate analog MCP, this area of the protein (shown as a yellow ribbon in Fig.…”
Section: Resultsmentioning
confidence: 99%